Are electronic signatures legally valid?

Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, electronic signatures are legally enforceable if intent, consent, attribution, and record retention requirements are met. Exceptions include wills, certain court filings, and other statutorily excluded categories.

Do I need a BAA for eSigning studies?

If the proposal or study workflow handles protected health information, a Business Associate Agreement is required under HIPAA. Platforms that sign a BAA help ensure PHI protections such as access controls, encryption, and breach notification are contractually enforced.

Which parties must sign the proposal?

Signatures are typically required from the Principal Investigator, authorized sponsor representative, and institutional signatories listed in site agreements. Ensure signatory authority is documented and that names match government IDs or institutional records to avoid attribution issues during audits.

Can IRBs accept e-signed consent forms?

Many IRBs accept electronically signed consent if the consent process documents signer identity, comprehension, and provides a retrievable record. IRB policies differ; include the IRB-required documentation and any ESIGN consumer disclosures when the consent involves subjects' rights in research.

When is notarization or witness required?

Notarization and witness requirements depend on state law and document type. Most consent forms do not require notarization, but state-specific declarations or power of attorney forms may. Verify local rules, and use RON where permitted to meet notarization needs.

How do I correct or amend a submitted proposal?

Submit formal amendment documentation to the IRB and sponsor, track version numbers, and update consent forms where required. Maintain audit logs showing who made changes and when; obtain re-consent from participants if amendments affect risks or participation obligations.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Study Proposal

Healthcare Clinical Study Proposal

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL STUDY PROPOSAL

Study Identification

Study Title:

Short Study Acronym (if any): Internal Study ID:

Principal Investigator

Full Legal Name Credentials / Title Institutional Affiliation and Address

Phone:

Email:

Sponsor / Funding Source

Sponsor Name Sponsor Contact

Study Overview

Brief Summary / Abstract Primary Objective Secondary Objectives

Study Design

Study Type: Interventional Observational Randomized Open-label Blinded

Phase: I II III IV

Estimated Sample Size Planned Study Start Date Planned Study End Date

Population, Inclusion and Exclusion

Target Population / Recruitment Plan Inclusion Criteria Exclusion Criteria

Study Procedures and Schedule

Procedures Concomitant Medications / Treatment Restrictions

Risk, Safety Monitoring, and Adverse Events

Known and Anticipated Risks Safety Monitoring Plan (DSMB, PI responsibilities)

Data Management and Confidentiality

Data Capture and Storage

HIPAA / Privacy protections will be followed. Investigator certifies that identifiable health information will be handled consistent with institutional policy and applicable law.

Authorization Expiration Date (if applicable): De-identification Plan:

Statistical Considerations

Statistical Analysis Plan

Regulatory and Ethics

Planned IRB / Ethics Committee Submission Date Regulatory Approvals Required

Budget, Resources and Facilities

Estimated Budget Summary Available Facilities & Key Personnel

Investigator Qualifications and Assurances

PI Curriculum Vitae (summary)

Certification: By signing below, the Principal Investigator certifies that the information in this proposal is complete and accurate to the best of their knowledge, that they will conduct the study in accordance with the approved protocol, applicable institutional policies, and all applicable laws and regulations, and that informed consent and appropriate HIPAA authorizations will be obtained where required.

Conflicts of Interest Disclosure:

Attachments and Appendices

Checklist of Included Attachments

Administrative Use

Proposal Received By: Date Received:

IRB/Committee Reference Number (if assigned):

Acknowledgments and Signatures

The Principal Investigator acknowledges responsibility for study conduct, participant safety, accurate recordkeeping, prompt reporting of adverse events, and compliance with applicable institutional and regulatory requirements.

Principal Investigator:

By:

Date:

Department Chair / Institutional Official:

By:

Date:

What the Healthcare Clinical Study Proposal Is

A Healthcare Clinical Study Proposal is a formal document that outlines the design, objectives, methodology, eligibility criteria, safety monitoring, and statistical analysis plan for a proposed clinical investigation. It typically includes background literature, study endpoints, enrollment targets, informed consent process, data management procedures, and budget. Sponsors, investigators, and Institutional Review Boards (IRBs) use the proposal to evaluate scientific merit, participant risk, and regulatory compliance. The proposal forms the basis for IRB submission, sponsor contracts, and regulatory filings such as an Investigational New Drug (IND) application when applicable.

Why a Clear Proposal Matters

A well-crafted Healthcare Clinical Study Proposal clarifies scientific rationale, protects participant safety, and documents controls needed for regulatory review. It streamlines sponsor and site decision-making, supports budget and resource planning, and establishes baseline commitments for ethics oversight and data integrity.

Who Prepares and Reviews This Proposal

Typical users include clinical investigators, study sponsors, contract research organizations, and institutional compliance officers reviewing protocols for ethics approval.

Principal Investigators — prepare protocol details and operational responsibilities for site execution.
Sponsors / CROs — submit design, budget, and regulatory materials to IRBs and agencies.
IRB members and ethics committees — evaluate risk/benefit, consent language, and monitoring plans.

Use this proposal when seeking IRB approval, negotiating site agreements, initiating regulatory submissions, or securing sponsor funding and resource commitments.

Core Sections to Include in a Professional Proposal

Core sections of a professional Healthcare Clinical Study Proposal define purpose, methodology, participant protections, data handling, safety oversight, and operational logistics required for ethical and regulatory review.

Study Overview

Summarize objectives, hypothesis, primary and secondary endpoints, target population, estimated enrollment, and rationale linking prior evidence to the proposed intervention and outcomes, including expected clinical significance and feasibility considerations.

Methods

Describe study design, randomization, blinding, control arms, intervention dosing and schedule, sample size justification, statistical analysis plan, and criteria for protocol amendments, including interim analyses and handling of missing data.

Eligibility

List inclusion and exclusion criteria, recruitment sources, screening procedures, and methods to verify eligibility while minimizing selection bias and protecting vulnerable populations, with documentation of consent capacity assessments where appropriate.

Safety Oversight

Define adverse event reporting, Data Safety Monitoring Board roles, stopping rules, periodic safety reviews, and expedited reporting timelines to regulators and IRBs, including contact details and escalation pathways for serious events.

Data Management

Specify data capture systems, source document requirements, data validation, de-identification approaches, storage security, access controls, and long-term preservation plans for audit readiness, including vendor qualifications and backup procedures.

Budget & Timeline

Provide itemized costs, payment schedules for sites, milestone deliverables, enrollment timelines, contingency allowances, and resource allocation for monitoring and regulatory submissions, with assumptions clearly stated to support contracting.

Security and Compliance Basics

PHI Handling: Limit access; follow HIPAA BAA.

Encryption: TLS 1.2/1.3 and AES-256 at rest

Audit Trail: Detailed timestamps, IP, signer identity

Access Controls: Role-based permissions and SSO

BAA Availability: Business Associate Agreement required

Certifications: SOC 2 Type II and ISO 27001

Step-by-Step: Prepare and Submit the Proposal

Follow these steps to complete a Healthcare Clinical Study Proposal and prepare it for IRB review, sponsor approval, and regulatory filing.

01

Draft: Assemble protocol, objectives, and study rationale.
02

Design: Define endpoints, sample size, and statistical plan.
03

Review: Internal review with collaborators and sponsors.
04

Submit: Prepare IRB package and submit per local requirements.

How to Configure an Online Submission Workflow

Configure an online workflow to collect eSignatures, route approvals, and attach required supporting documents for regulatory and sponsor review.

Form field, validation, and configuration	Configuration details and recommended values
Signer authentication method and strength	Email link, SMS code, or KBA; choose per risk
Field validation and required indicators	Set required fields, apply regex and length checks
Conditional routing and approval order	Route to sponsor, IRB, or monitoring board based on answers
Document attachments and version control	Attach protocol, consent forms, CVs; track revisions and timestamps

Where to Send the Finalized Proposal

Common destinations for a finalized Healthcare Clinical Study Proposal include institutional IRBs, sponsor regulatory affairs teams, clinical trial registries, and contract repositories used for site contracting.

IRB: Submit protocol package per site-specific submission checklist.
Sponsor: Send final proposal and budget to sponsor regulatory team.
Registry: Register trial details on ClinicalTrials.gov or applicable registry.
Site Contract: Provide finalized scope, milestones, and payment terms for contracting.

Technical Requirements for eSubmission Platforms

For eSubmission choose a platform that enforces encryption, audit logs, signer verification, and seamless integrations with EHRs and document repositories.

Integrations: Salesforce, NetSuite, Google Workspace supported.
File Types: Accept PDF, DOCX, and Excel files.
Authentication: Support SMS, email, SSO and optional KBA.

Typical Timelines and Review Expectations

Key timing expectations for proposal review and study initiation help manage enrollment, ethics approvals, and contracting across sponsor and site stakeholders.

Protocol finalization and internal approval:

Complete internal review and sponsor sign-off before IRB submission.

IRB submission and expected review timeframe:

Local IRB review commonly takes 30–60 days; timelines vary by board.

ClinicalTrials.gov registration and disclosure timeline:

Register applicable interventional trials within 21 days of first participant enrollment.

Contracting, budgets, and payment milestone timing:

Allow 30–90 days for site contracting and budget negotiations depending on complexity.

Regulatory filings such as IND or IDE:

If applicable, prepare IND/IDE materials early; FDA review timelines vary by program.

Common Preparation Mistakes to Avoid

Insufficient eligibility criteria clarity leading to enrollment of ineligible participants, protocol deviations, and increased monitoring burden that may delay study timelines and compromise validity.
Incomplete informed consent documents or unclear consent language that fails to disclose risks, data use, or withdrawal rights, risking IRB queries and participant complaints.
Poor data management plans without defined source documentation, monitoring frequency, or backup procedures increase regulatory audit risk and data integrity issues.
Neglecting privacy controls or failing to execute a Business Associate Agreement when PHI is involved may trigger HIPAA enforcement actions.

Potential Consequences of an Incorrect Proposal

IRB Nonapproval: Study cannot proceed

Regulatory Delay: FDA review delayed

Financial Loss: Sponsor funding withdrawn

Data Integrity Risk: Invalid or unusable data

HIPAA Sanctions: Fines and corrective actions

Contract Breach: Payment withholding or litigation

Practical Examples from Organizations Running Studies

Below are practical examples of how organizations use clinical study proposals to secure approvals, contracts, and operational readiness for multisite trials.

Fertility Centers of Illinois

Fertility Centers of Illinois used an electronic signing workflow to collect patient consents and streamline site administrative tasks across clinics.

Reduced turnaround time for consent collection.
John Butler, Founder, said the airSlate SignNow team was exceptional and responsive; the API supported integrations that improved document handling while preserving security and compliance across clinical sites and audit readiness.

Optica Ventures LLC

A small contract research sponsor used digital proposals to standardize site contracts, reduce manual signatures, and centralize version control across multiple sites.

Improved contract consistency and tracking.
Brian Fitzgibbons, COO, noted that the interface was simple and easy to use for both staff and external partners; the sponsor reported fewer signature errors and faster agreement execution supporting earlier site activation.

eSignature Pricing and Feature Comparison for Clinical Workflows

Compare typical eSignature vendor pricing and features relevant to Healthcare Clinical Study Proposal workflows, with signNow listed first for reference.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions and Troubleshooting

Answers to common questions about preparing, signing, and submitting Healthcare Clinical Study Proposals electronically, including legal and compliance considerations.

Need help? Contact support

Are electronic signatures legally valid?
Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, electronic signatures are legally enforceable if intent, consent, attribution, and record retention requirements are met. Exceptions include wills, certain court filings, and other statutorily excluded categories.
Do I need a BAA for eSigning studies?
If the proposal or study workflow handles protected health information, a Business Associate Agreement is required under HIPAA. Platforms that sign a BAA help ensure PHI protections such as access controls, encryption, and breach notification are contractually enforced.
Which parties must sign the proposal?
Signatures are typically required from the Principal Investigator, authorized sponsor representative, and institutional signatories listed in site agreements. Ensure signatory authority is documented and that names match government IDs or institutional records to avoid attribution issues during audits.
Can IRBs accept e-signed consent forms?
Many IRBs accept electronically signed consent if the consent process documents signer identity, comprehension, and provides a retrievable record. IRB policies differ; include the IRB-required documentation and any ESIGN consumer disclosures when the consent involves subjects' rights in research.
When is notarization or witness required?
Notarization and witness requirements depend on state law and document type. Most consent forms do not require notarization, but state-specific declarations or power of attorney forms may. Verify local rules, and use RON where permitted to meet notarization needs.
How do I correct or amend a submitted proposal?
Submit formal amendment documentation to the IRB and sponsor, track version numbers, and update consent forms where required. Maintain audit logs showing who made changes and when; obtain re-consent from participants if amendments affect risks or participation obligations.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now